Roche Respiratory Solutions can assist experts in diagnosing, correctly treating, and discharging patients faster, potentially easing the burden on healthcare professionals and helping to reduce winter pressures.
Rapid respiratory test results help empower clinicians to deliver treatment at the earliest possible stage – potentially reducing the risk of escalation and improving patient outcomes.
The Roche solution includes tests, technologies and transformation support for introducing rapid respiratory testing into any clinical setting - bringing care closer to the patient.
Quick, targeted near-patient respiratory testing
Roche cobas® liat delivers gold-standard PCR testing at the point of care.
Clinically actionable results for flu A/B, RSV and SARS-CoV-2 are available in 20 minutes.
Rapid results can help clinicians provide appropriate advice, guidance, and treatment at the right time and place.
Moving respiratory testing to local clinics and the community could help reduce pressure on primary and secondary care providers.
Rapid, targeted results
?wid=402&fmt=png-alpha&fit=crop,1)
Actionable results in 20 minutes
Frontline multiplex assays
Fast, reliable and robust respiratory testing
Every hospital admission in winter – whether through A&E or onto a ward – can be a risk.
Roche cobas® liat can rapidly diagnose flu A/B, RSV and SARS-CoV-2 in 20 minutes, helping to improve patient management, and provide appropriate treatment when required for patients while also giving reassurance for patients and healthcare providers.
Rapid, targeted results
Actionable results in 20 minutes
Frontline multiplex assays
High-throughput molecular diagnostic testing
Roche cobas® 5800, 6800 and 8800 systems aim to consolidate up to 90% of routine molecular testing into a single workflow,[1] enabling under-pressure lab staff to focus on adding value in other areas.
Roche’s advanced cobas® Respiratory flex is a flexible, high-throughput, syndromic test that can be customised by clinicians. They can order respiratory tests that are optimised for settings and address seasonality, local dynamics and patient cohort.
Flexible syndromic testing
High-throughput multiplex
?wid=402&fmt=png-alpha&fit=crop,1)
Reliable and robust
Precision respiratory testing
In complex cases, clinicians need diagnostic confidence to help enable them to select the most appropriate treatment and make informed prescribing decisions.
Roche cobas® eplex can perform rapid syndromic diagnosis, testing a single sample for 20 conditions and delivering a result in 90 minutes.
Tests 20+ respiratory targets
?wid=402&fmt=png-alpha&fit=crop,1)
Easy to use workflow
?wid=402&fmt=png-alpha&fit=crop,1)
Urgent results for high-risk patients
Our easy-to-operate tools and technologies are proven to deliver accurate diagnostics where they are needed most; in the community, in clinics, in hospitals, helping to protect high-risk patients.
Quick, targeted near-patient respiratory testing
Quick, targeted near-patient respiratory testing
Fast, reliable and robust respiratory testing for patient-centred care
Fast, reliable and robust respiratory testing for patient-centred care
High-throughput molecular diagnostic testing
High-throughput molecular diagnostic testing
Rapid syndromic diagnosis
Rapid syndromic diagnosis
Roche has developed a comprehensive range of rapid respiratory tests, technologies and assays for primary, secondary and community care settings. We are helping the NHS to transform what’s possible with respiratory testing.
Roche has developed a comprehensive range of rapid respiratory tests, technologies and assays for primary, secondary and community care settings. We are helping the NHS to transform what’s possible with respiratory testing.
Dr Chris Turner explores the evidence around the benefits and impact of near patient testing in primary care. Evidence shows point of care testing (POC) is a cost-effective way to diagnose patients faster than ever, helping empower doctors with the diagnostic confidence to make the best treatment decisions for each patient.
Dr Chris Turner explores the evidence around the benefits and impact of near patient testing in primary care. Evidence shows point of care testing (POC) is a cost-effective way to diagnose patients faster than ever, helping empower doctors with the diagnostic confidence to make the best treatment decisions for each patient.
Managing respiratory infections affects everyone who relies on healthcare systems.
Managing respiratory infections affects everyone who relies on healthcare systems.
A health service transformation expert, Sheila helped lead several point-of-care respiratory testing pilots across the UK.
A health service transformation expert, Sheila helped lead several point-of-care respiratory testing pilots across the UK.
Respiratory illnesses – including seasonal flu epidemics, RSV, Strep A and COVID-19 (SARS-CoV-2) – pose considerable challenges to NHS primary and secondary care providers.1
Respiratory illnesses – including seasonal flu epidemics, RSV, Strep A and COVID-19 (SARS-CoV-2) – pose considerable challenges to NHS primary and secondary care providers.1
The cobas® liat analyser is an automated nucleic acid test instrument, that when used together with cobas® liat assay tubes to perform in vitro diagnostic tests, is referred to as the cobas® liat system
The cobas® liat analyser is an automated nucleic acid test instrument, that when used together with cobas® liat assay tubes to perform in vitro diagnostic tests, is referred to as the cobas® liat system
Introducing the cobas® Respiratory flex assay, designed to enhance your diagnostic capabilities with Roche-developed innovative TAGS (temperature activated generation of signal) technology.
Introducing the cobas® Respiratory flex assay, designed to enhance your diagnostic capabilities with Roche-developed innovative TAGS (temperature activated generation of signal) technology.
The ePlex® System sample-to-answer solution streamlines the diagnostic workflow from your order entry to the release of the final report.
The ePlex® System sample-to-answer solution streamlines the diagnostic workflow from your order entry to the release of the final report.
Rapid frontline multiplex testing in clinics and point of entry covering common respiratory targets
High throughput, flexible, multiplex testing in hospitals for 12 most common viral respiratory pathogens
Comprehensive, fast syndromic testing of 20+ respiratory targets for high-risk patients
References
[1] (2024). Roche. Available at: https://diagnostics.roche.com/global/en/products/instruments/cobas-8800-ins-2694.html (Accessed: 2 October 2024).
